Delivery Order SPE2DX22D0129-SPE2D826F0AQA
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 27, 2025, with a ceiling value of $1,891.57 and an ultimate completion date of October 28, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made without set-aside...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,666.17 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply delivery to support federal healthcare requirements. The contract is performed from AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on October 7, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $150,264.46 and is due for completion by October 8, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,447.93 on November 10, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-competitive delivery order is expected to be completed by November 12, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,618.77 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 1, 2025, with completion targeted for October 2, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The award was made through competitive procurement with no...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,783.04 to AmerisourceBergen Drug Corp on November 18, 2025, with completion scheduled for November 19, 2025. This firm fixed-price, non-competitive delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $26,354.62 to AmerisourceBergen Drug Corp on November 10, 2025, with completion scheduled for November 12, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was issued with no set-aside...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $30,169.08 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order, which is not set-aside designated, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $4,028.55 from the Defense Logistics Agency's Medical Supply Chain on October 27, 2025. This firm fixed price delivery order, which serves as a child contract under a larger indefinite delivery vehicle, is non-competitive and carries a completion deadline of October 28, 2025. The award reflects AmerisourceBergen's ongoing role as a critical federal...
- The Defense Logistics Agency's Medical Supply Chain awarded a $2,583 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 20, 2025, with completion expected by October 21, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The delivery order will be performed at...
- SPE2DX22D0129Indefinite Delivery Contract
- SPE2DX22D0129-SPE2D826F0AQADelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 20, 2025, for a ceiling value of $10,750.82. This firm fixed price delivery order, which is expected to be completed by October 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made on a competitive basis without set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies an extensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The company serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard through this flexible contract mechanism, which positions it as a primary source for global pharmaceutical support across Defense Department medical programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 10/20/25 |